Panacea Biotec Limited
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company's product portfolio includes prescription products in various therapeu… Read more
Panacea Biotec Limited (PANACEABIO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.001x
Based on the latest financial reports, Panacea Biotec Limited (PANACEABIO) has a cash flow conversion efficiency ratio of -0.001x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹-7.70 Million) by net assets (₹8.22 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Panacea Biotec Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Panacea Biotec Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Panacea Biotec Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Panacea Biotec Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
REITMANS CDA LTD
F:CX40
|
N/A |
|
3D Global Biotech Inc.
TWO:6808
|
0.087x |
|
Centro de Imagem Diagnósticos S.A
SA:AALR3
|
0.071x |
|
Orthex Oyj
HE:ORTHEX
|
0.158x |
|
Udaipur Cement Works Limited
NSE:UDAICEMENT
|
0.038x |
|
Panda Financial Holding Corp Ltd
SHG:600599
|
0.459x |
|
OCK Group Bhd
KLSE:0172
|
-0.030x |
|
Galaxy Gaming Inc
OTCQB:GLXZ
|
-0.059x |
Annual Cash Flow Conversion Efficiency for Panacea Biotec Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Panacea Biotec Limited from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹8.31 Billion | ₹-273.70 Million | -0.033x | -27520.59% |
| 2024-03-31 | ₹8.38 Billion | ₹-1.00 Million | 0.000x | +99.98% |
| 2023-03-31 | ₹8.40 Billion | ₹-4.22 Billion | -0.503x | -305.10% |
| 2022-03-31 | ₹8.74 Billion | ₹-1.08 Billion | -0.124x | +73.03% |
| 2021-03-31 | ₹-2.32 Billion | ₹1.07 Billion | -0.460x | -198.09% |
| 2020-03-31 | ₹1.96 Billion | ₹-302.27 Million | -0.154x | -151.36% |
| 2019-03-31 | ₹3.47 Billion | ₹1.04 Billion | 0.301x | -22.12% |
| 2018-03-31 | ₹3.06 Billion | ₹1.18 Billion | 0.386x | +8.19% |
| 2017-03-31 | ₹3.66 Billion | ₹1.31 Billion | 0.357x | +76.93% |
| 2016-03-31 | ₹4.50 Billion | ₹906.90 Million | 0.202x | +157.15% |
| 2015-03-31 | ₹4.75 Billion | ₹372.30 Million | 0.078x | -24.36% |
| 2014-03-31 | ₹5.18 Billion | ₹537.30 Million | 0.104x | +373.26% |
| 2013-03-31 | ₹6.33 Billion | ₹-240.20 Million | -0.038x | -114.67% |
| 2012-03-31 | ₹8.82 Billion | ₹2.28 Billion | 0.259x | +117.23% |
| 2011-03-31 | ₹6.55 Billion | ₹780.30 Million | 0.119x | +35.14% |
| 2010-03-31 | ₹7.06 Billion | ₹621.71 Million | 0.088x | +898.58% |
| 2009-03-31 | ₹6.20 Billion | ₹-68.37 Million | -0.011x | -111.50% |
| 2008-03-31 | ₹6.96 Billion | ₹668.13 Million | 0.096x | -72.65% |
| 2007-03-31 | ₹4.47 Billion | ₹1.57 Billion | 0.351x | -46.08% |
| 2006-03-31 | ₹2.46 Billion | ₹1.60 Billion | 0.651x | +363.41% |
| 2005-03-31 | ₹2.12 Billion | ₹297.74 Million | 0.140x | -- |